cyclin-dependent kinase inhibition [CDK]

Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Mon, 10/21/13 - 05:55 pm
Novartis
cyclin-dependent kinase inhibition [CDK]
Pfizer
palbociclib
LEE011
Cyclin-Dependent Cancer Confab Preview
Seeking Alpha
Sun, 04/18/10 - 12:13 pm
cyclin-dependent kinase inhibition [CDK]
cancer
Pfizer
Cyclacel
Merck
Sanofi
Bayer
Tragara Pharmaceutical